{
  "id": "2e5e28dc51a8ba4d",
  "title": "STAT+: Pharmalittle: We\u2019re reading about obesity drug sales, India\u2019s biopharma research push, and more",
  "description": "The long-held expectation that the global market for obesity drugs would reach $150 billion in the next decade is looking a lot less certain",
  "content": "The long-held expectation that the global market for obesity drugs would reach $150 billion in the next decade is looking a lot less certain",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/02/02/obesity-lilly-novo-sanofi-india-pfizer-fda/?utm_campaign=rss",
  "published_at": "2026-02-02T14:30:17+00:00",
  "fetched_at": "2026-02-03T00:29:56.519436+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about obesity drug sales, India\u2019s biopharma research push, and more",
    "description": "The long-held expectation that the global market for obesity drugs would reach $150 billion in the next decade is looking a lot less certain",
    "url": "https://www.statnews.com/pharmalot/2026/02/02/obesity-lilly-novo-sanofi-india-pfizer-fda/?utm_campaign=rss",
    "published": "2026-02-02T14:30:17+00:00",
    "source": "STAT"
  }
}